Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 2, 1990 - Issue 4
12
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Subchronic Inhalation Studies on Polychlorotrifluoroethylene (3.1 Oil)

, , , , , & show all
Pages 433-451 | Received 13 Mar 1990, Accepted 17 Apr 1990, Published online: 27 Sep 2008
 

Abstract

3.1 Oil, an oligomer of chlorotrifluoroethylene (CTFE), is an inert, nonflammable, saturated and hydrogen-free chlorofluorocarbon oil of interest to the Department of Defense (DOD) as a potential hydraulic fluid. To determine the potential subchronic inhalation toxicity of this CTFE oligomer, male and female F-344 rats were exposed to air only or to 0.25, 0.50, or 1.00 mg/l of CTFE oligomer in 65 6-h inhalation exposures over a 90-day period. A dose-dependent depression in body weight gains was noted in male rats only Serum alkaline phosphatase, aspartate aminotransferase, and alanine aminotransferase activities examined at the conclusion of the study indicated a treatment-related effect in the male test rats, but not the female test rats. Notable concentration-related increases (p < .07) in relative kidney and liver weights occurred in both sexes of rats at all test concentrations. The male rats showed slight to minimal hyaline droplet formation in the kidney proximal tubule epithelium. Pronounced cy-tomegaly of hepatocytes was the predominant lesion recognized.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.